Correction to: Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen
- PMID: 36418612
- DOI: 10.1007/s10072-022-06522-w
Correction to: Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen
Erratum for
-
Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen.Neurol Sci. 2023 Jan;44(1):329-337. doi: 10.1007/s10072-022-06403-2. Epub 2022 Sep 29. Neurol Sci. 2023. PMID: 36175810
Publication types
LinkOut - more resources
Full Text Sources

